Search - tctmd.com

Displaying 641 - 660 of 806

Sort: Relevancy | Date

Presentation ACC 2013

Three-Year Results of the PLATINUM Randomized Trial Comparing Platinum Chromium PROMUS Element and Cobalt Chromium PROMUS/XIENCE V Everolimus-Eluting Stents

Presenter: Ian T. Meredith

March 09, 2013

Presentation ACC 2013

One-Year Outcome of a Trial Comparing Second Generation Drug-eluting Stents Using Either Biodegradable Polymer or Durable Polymer

Presenter: Masahiro Natsuaki

March 09, 2013

Presentation

Randomized Comparison of Sirolimus-eluting (SES) and Everolimus-eluting (EES) Coronary Stents in the Treatment of Total Coronary Occlusions

Presenter: 13956|Raul Moreno

February 24, 2013

Presentation CTO 2013

Case 5: When the Crossover Stent Technique Fails: Converting to Two Stents

Presenter: Andrejs Erglis

February 22, 2013

Presentation

Paclitaxel-Eluting Balloons, Paclitaxel-Eluting Stents, and Balloon Angioplasty in Patients with Restenosis After DES Implantation

Presenter: Robert A. Byrne

February 07, 2013

Presentation TCT 2013

The Impact Of First- versus Second-Generation Drug-Eluting Stents On Immediate- and Intermediate-Term Outcomes In A Complex ST-Segment Elevation Myocardial Infarction Population

Presenter: Joshua Loh, Hironori Kitabata, Israel Barbash, Danny Dvir, Salem Badr, Rebecca Torguson, Kenneth Kent, Lowell Satler, William Suddath, Augusto Pichard, Ron Waksman

January 31, 2013

Presentation TCT 2013

Two-Year Outcomes Following Implantation of 32mm and 38mm Platinum Chromium Everolimus Eluting Element Stents in Long Coronary Lesions

Presenter: Paul Teirstein, Gregg Stone, Ian Meredith, Robert Feldman, Joseph Dens, Abram Rabinowitz, Christophe Dubois, Dominic Allocco, Keith Dawkins

January 31, 2013

Presentation TCT 2013

Two zotarolimus-eluting stent generations: a meta-analysis of 12 randomized trials versus other limus-eluting stents and an adjusted indirect comparison.

Presenter: Salvatore Cassese, Gjin Ndrepepa, Lamin King, Tomohisa Tada, Massimiliano Fusaro, Adnan Kastrati

January 31, 2013

Presentation TCT 2013

Two Year Outcomes Following Unprotected Left Main Stenting with First- vs. New-Generation Drug-Eluting Stents: The FINE Registry

Presenter: Gill Buchanan, Alaide Chieffo, Chiara Bernelli, Matteo Montorfano, Mauro Carlino, Azeem Latib, Filippo Figini, Irene Franzoni, Santo Ferrarello, Alfonso Ielasi, Francesco Sacco, Massimo Slavich, Alessandro Durante, Alfredo Castelli, Antonio Colombo

January 31, 2013

Presentation TCT 2013

T-stenting with Two Drug-Eluting Stents Versus One Drug-Eluting Stent with Side Branch PTCA: Long-Term Pathological Findings in Bifurcation Lesions

Presenter: Seung-Jin Oh, Armando Tellez, Maxwell Afari, Gerard Conditt, Jenn McGregor, Yanping Cheng, Geng-Hua Yi, Renu Virmani, Juan Granada, Greg Kaluza

January 31, 2013

Presentation TCT 2013

Successful EVAR For Short-necked Abdominal Aortic Aneurysms Using Balloon Expandable Stents By Interventional Cardiologists

Presenter: Abhijeet Basoor, Kirit Patel, Abdul Halabi, Nishit Choksi, Thanh Phan, Michele DeGregorio

January 31, 2013

Presentation TCT 2013

Serial Evaluation Of Peri-strut Low Intensity Area On Optical Coherence Tomography After Drug-eluting Stents Implantation

Presenter: Eui Im, Byeong-Keuk Kim, Jung-Sun Kim, Dong-Ho Shin, Young-Guk Ko, Donghoon Choi, Yangsoo Jang, Myeong-Ki Hong

January 31, 2013

Presentation TCT 2013

Randomized Comparison of Direct Stenting with Conventional and Provisional Stent Implantation in Elective PCI Patients Using Bare Metal and Drug Eluting Stents

Presenter: Samer Somi, Wouter Remkes, Jan-Henk Dambrink, Marcel Gosselink, Jan Hoorntje, Harry Suryapranata, Jan Paul Ottervanger, Arnoud van 't Hof

January 31, 2013

Presentation TCT 2013

Randomized comparison of Biolimus-eluting (Nobori) and Everolimus-eluting (Xience/Promus) stents in patients with multivessel coronary artery disease: 12-month follow-up data...

Presenter: Peter Smits, A. J. van Boven, Mariano Valdes, Antonio Serra, Jean-Jacques Goy, V. Voudris, Ramiro Trillo, J. M. Vazquez, Peter den Heijer, Ton Slagboom, A.G. Vuillomenet

January 31, 2013

$Partial strut fracture in everolimus-eluting stents: An intravascular ultrasound study$

Presentation TCT 2013

Partial strut fracture in everolimus-eluting stents: An intravascular ultrasound study

Presenter: Shinji Inaba, Gary Mintz, Kyeong Yun, Tadayuki Yakushiji, Takehisa Shimizu, Giora Weisz, Martin Leon, Jeffrey Moses, Gregg Stone, Akiko Maehara

January 31, 2013

Presentation TCT 2013

Outcomes According to Sex Following Unprotected Left Main Stenting With Drug-Eluting Stents: The Milan Experience

Presenter: Gill Buchanan, Alaide Chieffo, Chiara Bernelli, Alfonso Ielasi, Matteo Montorfano, Azeem Latib, Mauro Carlino, Filippo Figini, Irene Franzoni, Francesco Giannini, Alessandro Durante, Santo Ferrarello, Alfredo Castelli, Antonio Colombo

January 31, 2013

Presentation TCT 2013

One year clinical outcome of biodegradable and permanent polymer drug-eluting stents for multivessel disease or long lesion (?28mm) in patients with stable and unstable angina

Presenter: Jun-Won Lee, Sung Gyun Ahn, Ji-Hyun Lee, Seung-Hwan Lee, Junghan Yoon, Young-Jin Youn

January 31, 2013

Presentation TCT 2013

Long-Term Follow-Up After Percutaneous Coronary Intervention With Polytetrafluoroethylene-Covered SYMBIOT Stents Compared To Bare Metal Stents, With And Without FilterWire Embol...

Presenter: Johan Bennett, Jo Dense, Francis Stammen, Patrick Coussement, Luc Janssens, Marc Claeys, Mathias Vrolix, Peter Sinnaeve, Christophe Dubois, Walter Desmet

January 31, 2013

Presentation TCT 2013

Long Term Outcomes Of Simple And Complex Coronary Bifurcation Lesions (CBL) Treated With Drug Eluting Stents (DES)

Presenter: Leonard Ngunga, Po Kee Cheung, Shantu Bundhoo, Neil Brass, Benjamin Tyrrell, Raymond Leung, Micha Dorsch, William Hui

January 31, 2013

Presentation TCT 2013

Late Catch-up Restenosis of Drug Eluting Stents: Evidence from Comparison with Bare Metal Stents in Japanese CAD Patients

Presenter: Yuki Horita, Masatoshi Ikeda, Isao Inoki, Masanobu Namura, Kenji Sakata, Hedenobu Terai

January 31, 2013

Advertisement

Three-Year Results of the PLATINUM Randomized Trial Comparing Platinum Chromium PROMUS Element and Cobalt Chromium PROMUS/XIENCE V Everolimus-Eluting Stents

One-Year Outcome of a Trial Comparing Second Generation Drug-eluting Stents Using Either Biodegradable Polymer or Durable Polymer

Randomized Comparison of Sirolimus-eluting (SES) and Everolimus-eluting (EES) Coronary Stents in the Treatment of Total Coronary Occlusions

Case 5: When the Crossover Stent Technique Fails: Converting to Two Stents

Paclitaxel-Eluting Balloons, Paclitaxel-Eluting Stents, and Balloon Angioplasty in Patients with Restenosis After DES Implantation

The Impact Of First- versus Second-Generation Drug-Eluting Stents On Immediate- and Intermediate-Term Outcomes In A Complex ST-Segment Elevation Myocardial Infarction Population

Two-Year Outcomes Following Implantation of 32mm and 38mm Platinum Chromium Everolimus Eluting Element Stents in Long Coronary Lesions

Two zotarolimus-eluting stent generations: a meta-analysis of 12 randomized trials versus other limus-eluting stents and an adjusted indirect comparison.

Two Year Outcomes Following Unprotected Left Main Stenting with First- vs. New-Generation Drug-Eluting Stents: The FINE Registry

T-stenting with Two Drug-Eluting Stents Versus One Drug-Eluting Stent with Side Branch PTCA: Long-Term Pathological Findings in Bifurcation Lesions

Successful EVAR For Short-necked Abdominal Aortic Aneurysms Using Balloon Expandable Stents By Interventional Cardiologists

Serial Evaluation Of Peri-strut Low Intensity Area On Optical Coherence Tomography After Drug-eluting Stents Implantation

Randomized Comparison of Direct Stenting with Conventional and Provisional Stent Implantation in Elective PCI Patients Using Bare Metal and Drug Eluting Stents

Randomized comparison of Biolimus-eluting (Nobori) and Everolimus-eluting (Xience/Promus) stents in patients with multivessel coronary artery disease: 12-month follow-up data...

Partial strut fracture in everolimus-eluting stents: An intravascular ultrasound study

Outcomes According to Sex Following Unprotected Left Main Stenting With Drug-Eluting Stents: The Milan Experience

One year clinical outcome of biodegradable and permanent polymer drug-eluting stents for multivessel disease or long lesion (?28mm) in patients with stable and unstable angina

Long-Term Follow-Up After Percutaneous Coronary Intervention With Polytetrafluoroethylene-Covered SYMBIOT Stents Compared To Bare Metal Stents, With And Without FilterWire Embol...

Long Term Outcomes Of Simple And Complex Coronary Bifurcation Lesions (CBL) Treated With Drug Eluting Stents (DES)

Late Catch-up Restenosis of Drug Eluting Stents: Evidence from Comparison with Bare Metal Stents in Japanese CAD Patients

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content